Adaptive Biotechnologies ADPT Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's operating lease liabilities (total)?
- Adaptive Biotechnologies (ADPT) reported operating lease liabilities (total) of $77.63M in Q1 2026.
- How has Adaptive Biotechnologies's operating lease liabilities (total) changed year-over-year?
- Adaptive Biotechnologies's operating lease liabilities (total) decreased by 10.7% year-over-year, from $86.9M to $77.63M.
- What is the long-term trend for Adaptive Biotechnologies's operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's operating lease liabilities (total) has grown at a -6.0% compound annual growth rate (CAGR), from $107.86M to $79.15M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.